Would you consider neoadjuvant endocrine therapy instead of chemotherapy for a pre-menopausal patient with a node-positive, ER+PR+, lobular breast cancer?  

Initial pathology additionally yields low Ki-67 and is HER2 negative. 



Answer from: Medical Oncologist at Academic Institution